Millennial Pharmaceuticals Private Limited, a active private limited company, was established on 31 March 2020 in Serilingampally, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51900TG2020PTC140019. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Shaik Ismail Saheb (Director), Zahera Banu (Director). Past directors included Shaik Ismail Saheb, Shaik Mahaboob Basha, Syed Ghouse. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No 3-67/3/536, Ground Floor, Shop No .01 & 02, Nallagandla, Serlingampally, Serilingampally, Telangana, 500019.
U51900TG2020PTC140019
140019
31 March 2020
₹0.50 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Millennial Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shaik Ismail Saheb | Director | 13 Feb 2023 | Current |
| Zahera Banu | Director | 15 Oct 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Nov 2022 | Past |
| Pramod Abcsdd | Additional Director | 10 Oct 2024 | Past |
| Pramod Abcsdd | Director | 15 Oct 2024 | Past |
| Pramod Abcsdd | Director | 29 Mar 2024 | Past |
| Pramod Abcsdd | Director | 21 May 2021 | Past |
| Pramod Abcsdd | Additional Director | 14 Feb 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Millennial Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 111.48% increase. The company also saw a substantial improvement in profitability, with a 398.39% increase in profit. The company's net worth Soared by an impressive increase of 205.18%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Millennial Pharmaceuticals had a public holding of 70.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Millennial Pharmaceuticals has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Millennial Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Millennial Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Zahera Banu was appointed as a Director was appointed as a Director on 15 Oct 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.
Progress on Millennial Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Millennial Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
Progress on Shaik Ismail Saheb was appointed as a Director was appointed as a Director on 13 Feb 2023 & has been associated with this company since 2 years 10 months . was documented.
The activity Millennial Pharmaceuticals Private Limited was registered on 31 Mar 2020 with Roc Hyderabad & aged 5 years 8 months as per MCA records. was completed.
The CIN of Millennial Pharmaceuticals Private Limited is U51900TG2020PTC140019.
Millennial Pharmaceuticals Private Limited is headquartered at H.No 3-67/3/536, Ground Floor, Shop No .01 & 02, Nallagandla, Serlingampally, Serilingampally, Telangana, 500019.
Millennial Pharmaceuticals Private Limited was incorporated on 31 March 2020.
The current directors of Millennial Pharmaceuticals Private Limited are
The primary industry of Millennial Pharmaceuticals Private Limited is Manufacturing.
Millennial Pharmaceuticals Private Limited is unlisted.
The authorized capital of Millennial Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX